224 filings
Page 5 of 12
8-K
xrlyg8mwgyt8b
30 Sep 20
Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent Litigation
8:00am
8-K
f8uvj72hs pf2a1
25 Sep 20
Collegium Appoints Rita Balice-Gordon to its Board of Directors
4:03pm
S-8
8a0582iz
13 Aug 20
Registration of securities for employees
4:06pm
8-K
o05qb89nn8kjrs2
5 Aug 20
Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020
4:01pm
8-K
8ln5v3y98m sqbkqfmt
9 Jul 20
Departure of Directors or Certain Officers
5:00pm
8-K
eut53dd2c
22 May 20
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
31lemj8e1h0y7klmzre
7 May 20
Collegium Reports First Quarter 2020 Profitability
4:01pm
DEFA14A
cvxjvbz wwxbufn
9 Apr 20
Additional proxy soliciting materials
4:09pm
EFFECT
hpev8
31 Mar 20
Notice of effectiveness
12:15am
CORRESP
wjjzx04zdn0vi4
27 Mar 20
Correspondence with SEC
12:00am
PRE 14A
yx7utz5
25 Mar 20
Preliminary proxy
4:01pm
UPLOAD
ol7dn
23 Mar 20
Letter from SEC
12:00am
8-K
ichiozbtmk2646610ok
27 Feb 20
Collegium Reports Full-Year 2019 Revenue of $296.7 Million
4:01pm
8-K
ttq7q6je9nr1tb
13 Feb 20
Collegium Announces Closing of the Nucynta Franchise Acquisition
5:10pm
424B5
jubnjwvv ur5072z96
11 Feb 20
Prospectus supplement for primary offering
4:08pm